NRG DT001

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Sarcoma

Status:

Temporarily Closed

A Phase Ib Trial of Neoadjuvant AMG-232 Concurrent with Preoperative Radiotherapy in Wild-Type P53 Soft Tissue Sarcoma (STS)

NCT#03217266

Effective, April 24th, 2020, NRG DT001, Cohort B, is reactivated to Dose Level 2.
Cohort A (extremity/body wall) at Dose level 3 remains open.